ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,518,000 | -31.2% | 213,625 | -36.3% | 0.76% | -37.5% |
| Q1 2018 | $8,018,000 | +68.4% | 335,500 | +138.8% | 1.22% | +117.7% |
| Q4 2017 | $4,762,000 | +94.8% | 140,500 | +21.6% | 0.56% | +60.2% |
| Q3 2017 | $2,445,000 | -28.5% | 115,500 | -40.9% | 0.35% | -39.9% |
| Q2 2017 | $3,419,000 | -0.1% | 195,500 | 0.0% | 0.58% | -13.2% |
| Q1 2017 | $3,421,000 | -25.0% | 195,500 | -27.6% | 0.67% | -42.1% |
| Q4 2016 | $4,563,000 | +3.0% | 270,000 | 0.0% | 1.16% | +60.2% |
| Q3 2016 | $4,431,000 | +8.4% | 270,000 | 0.0% | 0.72% | -32.0% |
| Q2 2016 | $4,088,000 | +4.7% | 270,000 | 0.0% | 1.06% | +25.4% |
| Q1 2016 | $3,904,000 | -8.1% | 270,000 | +80.0% | 0.85% | +36.0% |
| Q4 2015 | $4,248,000 | – | 150,000 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 808,431 | $3,501,000 | 2.68% |
| AIGH Capital Management LLC | 875,851 | $3,793,000 | 1.54% |
| Healthcare Value Capital, LLC | 100,000 | $433,000 | 1.46% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 440,955 | $1,909,000 | 1.11% |
| Opaleye Management Inc. | 1,487,800 | $6,442,000 | 0.84% |
| Worth Venture Partners, LLC | 225,106 | $975,000 | 0.77% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,873,000 | 0.40% |
| DELTEC ASSET MANAGEMENT LLC | 245,399 | $1,063,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 278,011 | $1,204,000 | 0.15% |
| Mosaic Family Wealth, LLC | 91,807 | $398,000 | 0.13% |